Data de publicação: 31/10/2024 - 14:51
The Center for Technological Development in Health (CDTS/Fiocruz) and China National Center for Bioinformation (known as CNCB) signed a memorandum of understanding (MoU) on Tuesday (10/22) for collaboration in the areas of Bioinformatics and Big Data in Biological Sciences. The document envisages not only partnerships in research and education, but also with a view to tackling national, regional and global challenges.
The director...
Notícias
Data de publicação: 31/10/2024 - 14:22
The president of Fiocruz, Mario Moreira, sent the declaration resulting from the G20 Conference of National Public Health Institutes to the minister of Health Nísia Trindade Lima, asking for the suggested measures to be implemented. The declaration recognizes the importance of the bloc of the world's largest economies in building a healthier and more equitable world and recommends that future presidencies of the group invite the...
Notícias
Data de publicação: 25/10/2024 - 09:38
President Mario Moreira has been reelected by the public servants of Fiocruz to serve a term from 2025 to 2028 at the head of the institution. The result of the 2024 Fiocruz Election for the Presidency was announced this Thursday (October 24), following the completion of the vote counting, which ended at 5 PM (Brasilia time). The candidate received 2,901 votes, which corresponds to 81.8% of the valid votes. A total of 3,546 votes were cast....
Notícias
Data de publicação: 24/10/2024 - 12:28
Key members of the Pasteur Network, including Fiocruz, through Bio-Manguinhos, the Institut Pasteur Dakar, the Institut Pasteur Korea, the Institut Pasteur (Paris), and the Institut Pasteur Tunis, have signed a strategic Memorandum of Understanding (MoU) to strengthen collaboration in vaccine research and development, part of one of the strategic pillars of the Pasteur Network. This partnership focuses on expanding mRNA vaccine production...
Notícias
Data de publicação: 22/10/2024 - 15:42
The incidence of tuberculosis has been increasing in Latin America, where the incarcerated population has nearly quadrupled since 1990. An unprecedented study conducted by Fiocruz in partnership with institutions from Argentina, Brazil, Colombia, Peru, and the United States assessed the total impact of the tuberculosis epidemic on the incarcerated population, accounting for effects beyond incarcerations – further considering transmission...
Notícias
Data de publicação: 22/10/2024 - 09:54
An unprecedented leprosy vaccine will be tested in Brazil by the Oswaldo Cruz Institute (IOC/Fiocruz). Called LepVax, the vaccine will be the first for the disease assessed in the country during clinical trials. The authorization to begin the trials was granted by the National Health Regulatory Agency (Anvisa) on Monday (10/14).
IOC/Fiocruz will lead the first clinical test of a vaccine for leprosy (photo: Gutemberg Brito)
The...
Notícias
Data de publicação: 21/10/2024 - 12:09
On October 31st, at 2pm (London), the webinar called “Preparing for the 2025 dengue season: insights from predictive models” will take place, promoted by the Vice-presidency of Education, Information and Communication of Fiocruz (VPEIC), via the Fiocruz Scientific Computing Program (PROCC) in partnership with the consortium The Global Health Network Latin America and the Caribbean (TGHN LAC), by the Zoom platform. The event will be...
Notícias
Data de publicação: 21/10/2024 - 11:03
The Pasteur Network Annual Meeting 2024 (PNAM 2024) is taking place this year for the first time in the Americas, with Fiocruz as a co-organizer. The Opening Ceremony, which can have the presence of the press, happens this Monday (October 21) at 6 PM (RIO TIME) at the Windsor Oceânico Hotel (Rua Martinho de Mesquita, 129, Barra da Tijuca, Rio). Participants will include the Fiocruz president, Mario Moreira; the president of the Pasteur...
Notícias
Data de publicação: 17/10/2024 - 16:39
Fiocruz and GEMMA Biotherapeutics (GEMMABio) announced last Tuesday (10/8) an agreement to sponsor research focused on gene therapy treatments for the Brazilian population within the scope of the Unified Health System (SUS). The ultimate goal of the international partnership with the company founded by gene therapy expert Jim Wilson is to obtain approval for gene therapy programs that will enable the country to increase the distribution of...
Notícias
Data de publicação: 17/10/2024 - 16:17
October began with yet another heatwave in Brazil, the eighth that the country has faced in 2024. High temperatures in the Southeast, drought in the North, heavy rains in the South. Different scenarios point to a growing concern: the increase and frequency of extreme events and the risks they bring to public health. Recently, the Climate and Health Observatory of the Institute for Scientific and Technological Communication and Information in...
Notícias
Data de publicação: 17/10/2024 - 15:55
A strain of the Sars-CoV-2 virus that has been spreading around the world has been detected in Brazil. The strain called XEC, which belongs to the Omicron variant, has been identified in the states of Rio de Janeiro, São Paulo and Santa Catarina. It was first detected by the Oswaldo Cruz Institute (IOC/Fiocruz) in samples from two patients living in the capital of Rio de Janeiro, diagnosed with COVID-19 in September. The identification...
Notícias
Data de publicação: 11/10/2024 - 15:36
Brazil was the 20th country certified by the World Health Organization (WHO) for the elimination of lymphatic filariasis as a public health problem and the Institute of Drug Technology (Farmanguinhos/Fiocruz) played a key role in this achievement, as the only supplier of the drug used in the treatment registered in Brazil. Diethylcarbamazine 50mg was developed by the Institute and first registered in 1996, and it has been distributed throughout...
Notícias
Data de publicação: 09/10/2024 - 10:38
A study by Fiocruz Bahia used text mining to extract unstructured data from a Long-COVID research conducted at a university hospital in São Paulo. The aim of the work is to contribute to a deeper understanding of this chronic condition and its implications for global health systems. The model developed has potential for application in other healthcare settings, supporting broader research efforts and clinical decision-making for patients...
Notícias
Data de publicação: 02/10/2024 - 16:20
Sergio Arouca National School of Public Health (ENSP/Fiocruz), through the International Cooperation Advisory and the SUS (the Brazilian national public health system) Observatory, will host an international seminar from October 3rd to 4th, 2024, to discuss the health systems of Brazil and France.
The event will focus on territorial governance and Primary Health Care, bringing together experts and researchers from both countries to share...
Notícias
Data de publicação: 02/10/2024 - 14:01
Research led by Fiocruz has shown that the recent outbreak of Oropouche fever in the Amazon region, the widest ever recorded, was caused by a new viral strain, called 'OROV BR-2015-2024'. The peer-reviewed article was published in the prestigious international scientific journal Nature Medicine on an accelerated basis to allow early access to the findings. The final edited version of the paper will soon be published in the journal....
Notícias
Data de publicação: 02/10/2024 - 12:17
The Itaboraí Forum: Politics, Science and Culture in Health/Fiocruz Petrópolis is moving forward with the Multicentric project, an initiative that aims to apply Social Technology tools to reduce social inequalities as a determinant of health inequities in five vulnerable Latin American countries. Representatives from the National Public Health Institutes of Argentina, El Salvador and Mexico and from the Latin American School of...
Notícias
Data de publicação: 02/10/2024 - 11:16
We are currently entering a new frontier of knowledge, in which tackling chronic-degenerative diseases, associated with increased life expectancy, has become an undeniable priority. Many current cancer drugs, for example, are subject to failures, relapses and unwanted side effects such as cardiotoxicity and nephrotoxicity. However, with the advent of biological therapies and, more recently, advanced therapies, we are witnessing a real revolution...
Notícias
Data de publicação: 01/10/2024 - 11:16
A project developed by researchers from the Leônidas and Maria Deane Institute (Fiocruz Amazônia) and the René Rachou Institute (Fiocruz Minas), in collaboration with the Municipal Health Department of Belo Horizonte, shows that the "auto-dissemination" of larvicides by urban mosquitoes can help control diseases transmitted by these same mosquitoes, such as dengue. The project distributed an average of 2,500 "...
Notícias
Data de publicação: 26/09/2024 - 16:37
A technology for the manufacturing of low-cost, open-source 3D bioprinters, developed by the Oswaldo Cruz Institute (IOC/Fiocruz) in collaboration with Veiga de Almeida University (UVA), may soon reach the market. 3D bioprinting allows for creating artificial biological tissues with potential applications in biomedical research, human and animal health, and even in the food industry.
A bio-printer can produce three-dimensional structures...
Notícias
Data de publicação: 24/09/2024 - 13:03
In August, the Graduate Program in Biosciences and Biotechnology at the Carlos Chagas Institute (ICC/Fiocruz Paraná) made significant progress in consolidating its internationalization process. A scientific cooperation agreement was signed between Fiocruz Paraná and Institut Pasteur de Montevideo, in Uruguay. The objectives are to enrich the educational experience of both institutes, promote research of excellence and strengthen...
Notícias
Data de publicação: 19/09/2024 - 16:31
On September 6th, Fiocruz received a delegation from the World Bank Group made up of executive directors from several member countries led by the executive director for Brazil. The group, which was on a trip through Brazil, came to the Foundation to learn about its activities and, in particular, more about the Health Biotechnology Industrial Complex (Cibs) project at the Santa Cruz Campus of the Immunobiological Technology Institute (Bio-...
Notícias
Data de publicação: 19/09/2024 - 13:30
The Arca Dados, Fiocruz's official research data repository, received the CoreTrustSeal on Thursday (9/12), a seal from the non-profit organization CoreTrust which provides one of the most important international certifications legitimizing the platform as a reliable source. This is the first time that a Brazilian data repository has received the certification. The evaluators, who are part of an international data community, considered...
Notícias
Data de publicação: 18/09/2024 - 16:37
The Brazilian president of the Republic, Luiz Inácio Lula da Silva, and the minister of Health, Nísia Trindade Lima, presented the Oswaldo Cruz Medal of Merit on Wednesday (9/11) to 23 people and 10 institutions that have promoted efforts to tackle the drop in vaccination coverage in the country. The work of each of the honorees contributed to removing Brazil from the ranking of the 20 countries with the most unimmunized children,...
Notícias
Data de publicação: 16/09/2024 - 12:34
Fiocruz, through its graduate program in Bioethics, Applied Ethics and Collective Health, has become a collaborating member of the Global Health Bioethics Network, coordinated by the Oxford University - becoming the first Latin American institution to join the network, whose members include representatives from Asia and Africa. The coordinator of the Foundation's graduate program in Ethics, Sergio Rego, and the coordinator of the...
Notícias